🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 hora
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/2003 | 0,3531 USD |
| 03/09/2003 | 0,3531 USD |
| 20/08/2003 | 2,7443 USD |
| 04/06/2003 | 0,3435 USD |
| 05/03/2003 | 0,3435 USD |
| 04/12/2002 | 0,3435 USD |
| 04/09/2002 | 0,3435 USD |
| 05/06/2002 | 0,3340 USD |
| 06/03/2002 | 0,3340 USD |
| 05/12/2001 | 0,3340 USD |
| 30/08/2001 | 0,3340 USD |
| 31/05/2001 | 0,3244 USD |
| 07/03/2001 | 0,3244 USD |
| 06/12/2000 | 0,3244 USD |
| 30/08/2000 | 0,3244 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/09/2002 | 44,94 | 45,60 | 44,34 | 44,90 | -0,59% | 2,80% | 6.047.694 |
| 17/09/2002 | 47,32 | 47,38 | 44,86 | 45,17 | -3,01% | 5,32% | 6.726.483 |
| 16/09/2002 | 46,57 | 46,91 | 45,66 | 46,57 | -0,93% | 2,68% | 4.263.159 |
| 13/09/2002 | 46,66 | 47,28 | 45,80 | 47,01 | +0,35% | 3,17% | 4.223.335 |
| 12/09/2002 | 46,66 | 47,42 | 46,52 | 46,85 | -0,95% | 1,94% | 5.841.866 |
| 11/09/2002 | 47,85 | 48,02 | 47,19 | 47,30 | -0,14% | 1,73% | 2.908.934 |
| 10/09/2002 | 47,15 | 47,63 | 46,76 | 47,37 | +0,49% | 1,86% | 2.995.498 |
| 09/09/2002 | 46,37 | 47,68 | 46,18 | 47,14 | +1,65% | 3,23% | 5.137.506 |
| 06/09/2002 | 46,73 | 46,73 | 45,82 | 46,37 | +0,62% | 1,94% | 4.557.018 |
| 05/09/2002 | 45,80 | 46,74 | 45,09 | 46,09 | -1,69% | 3,60% | 6.679.428 |
| 04/09/2002 | 45,32 | 47,00 | 45,04 | 46,88 | +2,63% | 4,34% | 7.109.318 |
| 03/09/2002 | 47,19 | 47,47 | 45,56 | 45,68 | -5,25% | 4,04% | 6.717.261 |
| 30/08/2002 | 48,33 | 49,10 | 47,95 | 48,21 | -0,43% | 2,39% | 4.541.613 |
| 29/08/2002 | 47,48 | 49,14 | 47,48 | 48,42 | +0,20% | 3,50% | 4.260.015 |
| 28/08/2002 | 48,66 | 49,24 | 47,97 | 48,32 | -1,97% | 2,61% | 4.809.586 |
| 27/08/2002 | 50,08 | 50,58 | 49,07 | 49,29 | -1,92% | 3,01% | 4.505.142 |
| 26/08/2002 | 50,15 | 50,57 | 49,23 | 50,26 | +0,21% | 2,68% | 4.823.839 |
| 23/08/2002 | 51,07 | 51,34 | 49,63 | 50,15 | -2,30% | 3,34% | 5.145.680 |
| 22/08/2002 | 49,43 | 51,53 | 49,24 | 51,34 | +3,70% | 4,63% | 7.231.829 |
| 21/08/2002 | 48,55 | 49,74 | 48,51 | 49,50 | +2,45% | 2,54% | 5.145.785 |
| 20/08/2002 | 48,23 | 49,14 | 48,14 | 48,32 | -1,21% | 2,08% | 4.040.564 |
| 19/08/2002 | 47,71 | 49,43 | 47,71 | 48,91 | +2,52% | 3,60% | 4.838.721 |
| 16/08/2002 | 48,26 | 48,31 | 47,35 | 47,71 | -1,15% | 2,00% | 5.121.471 |
| 15/08/2002 | 48,66 | 49,33 | 47,54 | 48,26 | -1,00% | 3,69% | 5.719.460 |
| 14/08/2002 | 46,85 | 48,95 | 46,17 | 48,75 | +2,84% | 5,93% | 7.758.868 |
| 13/08/2002 | 48,28 | 49,04 | 47,34 | 47,40 | -3,06% | 3,52% | 5.493.406 |
| 12/08/2002 | 47,85 | 49,22 | 47,81 | 48,90 | +0,45% | 2,95% | 4.865.130 |
| 09/08/2002 | 47,95 | 49,17 | 47,31 | 48,68 | +1,33% | 3,88% | 7.465.952 |
| 08/08/2002 | 46,94 | 48,18 | 46,72 | 48,04 | +2,86% | 3,11% | 8.251.952 |
| 07/08/2002 | 45,11 | 46,75 | 44,57 | 46,71 | +4,53% | 4,82% | 6.080.391 |